Dexcom's Apple Watch app will be ready to go when the device launches in April, the company told the Wall Street Journal. The app, which will not need to seek pre-market approval from the FDA thanks ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

Wall Street expects a year-over-year increase in earnings on higher revenues when DexCom (DXCM) reports results for the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

This was the stock's third consecutive day of losses.

Shares of DexCom slid after the company reported mixed third-quarter results that included disappointing new patient numbers and lower gross margin guidance. The stock fell 15% to $58.10 and is down ...

DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...

Oct 30 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...